Abstract
Background: Proton beam therapy (PBT) is increasingly available to some patients with early breast cancer because it achieves better planned dose distributions than standard photon radiotherapy. But there are uncertainties around how planned PBT dose distributions relate to clinical outcomes. This study quantitatively summarises the adverse clinical outcomes of delivered PBT for early breast cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
